Quince Therapeutics, Inc. (QNCX) Stock Price History
Historical prices from 2019 to 2026
Loading 10-year price history...
QNCX Historical Performance
Short-Term Returns
QNCX Stock Price Trajectory (2019–2026)
As of May 8, 2026, Quince Therapeutics, Inc. (QNCX) trades at $1.28, representing a -87.6% return over the past year. The stock has delivered a -99.6% total return over five years (-67.1% CAGR), reflecting challenging market conditions.
The stock reached its all-time high of $1,219.80 on August 10, 2021. From this peak, QNCX has corrected -99.9%, currently trading 92% below its 200-day moving average, suggesting potential weakness.
When compared to Healthcare sector peers RARE (-27.4% 1Y), FOLD (+138.3% 1Y), and ACAD (+32.3% 1Y), QNCX has underperformed the peer group average. Compare QNCX vs RARE →
QNCX Historical Price Data (2025–2026)
Showing 30 of 1,761 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-08 | 1.28 | 1.32 | 1.20 | 1.28 | 1.23M | -1.54% |
| 2026-05-07 | 1.23 | 1.31 | 1.21 | 1.30 | 925K | +6.56% |
| 2026-05-06 | 1.24 | 1.29 | 1.22 | 1.22 | 736K | -0.81% |
| 2026-05-05 | 1.24 | 1.25 | 1.18 | 1.23 | 1.11M | +0.82% |
| 2026-05-04 | 1.27 | 1.30 | 1.21 | 1.22 | 955K | -8.27% |
| 2026-05-01 | 1.28 | 1.34 | 1.26 | 1.33 | 744K | +1.53% |
| 2026-04-30 | 1.20 | 1.32 | 1.20 | 1.31 | 655K | +6.50% |
| 2026-04-29 | 1.24 | 1.26 | 1.20 | 1.23 | 1.03M | 0.00% |
| 2026-04-28 | 1.25 | 1.27 | 1.17 | 1.23 | 1.60M | -4.65% |
| 2026-04-27 | 1.32 | 1.34 | 1.25 | 1.29 | 1.04M | -5.15% |
| 2026-04-24 | 1.37 | 1.37 | 1.31 | 1.36 | 1.18M | 0.00% |
| 2026-04-23 | 1.37 | 1.53 | 1.30 | 1.36 | 2.14M | -0.73% |
| 2026-04-22 | 1.35 | 1.43 | 1.34 | 1.37 | 1.52M | +2.24% |
| 2026-04-21 | 1.27 | 1.42 | 1.26 | 1.34 | 1.71M | +5.51% |
| 2026-04-20 | 1.24 | 1.41 | 1.23 | 1.27 | 1.75M | -7.30% |
| 2026-04-17 | 1.37 | 1.45 | 1.28 | 1.37 | 2.78M | +2.24% |
| 2026-04-16 | 1.18 | 1.40 | 1.17 | 1.34 | 2.91M | +8.94% |
| 2026-04-15 | 1.17 | 1.25 | 1.12 | 1.23 | 2.59M | -1.60% |
| 2026-04-14 | 1.25 | 1.33 | 1.20 | 1.25 | 3.03M | -11.35% |
| 2026-04-13 | 1.29 | 1.47 | 1.14 | 1.41 | 4.34M | +3.68% |
| 2026-04-10 | 1.15 | 1.54 | 1.13 | 1.36 | 117.37M | +9.68% |
| 2026-04-09 | 1.26 | 1.59 | 1.16 | 1.24 | 169.66M | -32.24% |
| 2026-04-08 | 3.34 | 3.84 | 1.70 | 1.83 | 1.14B | +12.27% |
| 2026-04-07 | 0.94 | 1.89 | 0.90 | 1.63 | 578.60M | +86.29% |
| 2026-04-06 | 0.98 | 0.98 | 0.88 | 0.88 | 23.18M | -11.62% |
| 2026-04-02 | 1.00 | 1.00 | 0.93 | 0.99 | 8.86M | -2.94% |
| 2026-04-01 | 1.01 | 1.08 | 0.98 | 1.02 | 14.86M | +0.99% |
| 2026-03-31 | 1.00 | 1.02 | 0.93 | 1.01 | 14.81M | 0.00% |
| 2026-03-30 | 1.13 | 1.14 | 0.92 | 1.01 | 167.44M | +15.30% |
| 2026-03-27 | 0.93 | 0.98 | 0.84 | 0.88 | 9.92M | -6.91% |
See QNCX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs QNCX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare QNCX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonQNCX — Frequently Asked Questions
Quick answers to the most common questions about buying QNCX stock.
How has QNCX stock performed recently?
QNCX declined -87.6% over the past year, below its 5-year annualized CAGR of -67.1%. The stock trades below its 200-day moving average, reflecting the downtrend.
What is QNCX's all-time high price?
Quince Therapeutics, Inc. reached $1219.80 on 2021-08-10. The 52-week high is $45.50. Current 1-year return of -87.6% places the stock further from historical peaks.
Where can I download QNCX historical price data?
This page provides QNCX daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2019-2026, downloadable in CSV format.